HEALTHSTORY 1095· JUNE 26, 2026

Delphia Therapeutics Names David Kerstein as Chief Medical Officer

Delphia Therapeutics has appointed David Kerstein as its chief medical officer. Kerstein arrives with direct experience in the role, having previously served as CMO at both IDRx and Theseus Pharmaceuticals — a track record that matters in…

NDNewsDialy Desk1 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 1094Democratic Senators Push FCC to Freeze Paramount-Warner Bros Discovery Merger on Foreign Ownership Grounds NEXT STORY 1096 →Four Ethereum Early Adopters Cash Out 37,602 ETH, Walking Away With $27M After $150M Peak Evaporated

Keep reading

More from the desk.

02HEALTH

Novartis shares drop 11% on drug failure as biosimilar gap threatens $200 billion in savings

A failed clinical trial wiped nearly $30 billion from Novartis's market value this week after shares fell 11% in a single session, erasing all the gains the stock had made since the start of the year. The drug that failed, del-desiran, was…

health2 MIN

10HEALTH

EU legal adviser hands pharma a win on wastewater costs

Pharmaceutical and cosmetics companies across Europe may be off the hook for the largest share of a continent-wide water cleanup effort, after a legal adviser to the EU's top court recommended striki

health2 MIN

11HEALTH

FDA clears first drug to target muscle loss in spinal muscular atrophy

Federal regulators approved a drug on Friday for spinal muscular atrophy, a rare neurological condition where the nerve cells that signal muscles to move gradually deteriorate. The drug, Isembyld, is the first approved therapy to directly…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk